ACXP
Price:
$1.57
Market Cap:
$2.49M
Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate is ibezapolstat, an antibiotic that utilizes a novel mechanism of action by targeting the polymerase IIIC enzyme. Ibezapolstat has successfully completed Phase II clinical trials for addressing Clostridium difficile infections. Additionally, Acurx is progressing with ACX-375C, an investigational therapeutic suitable for both oral and injectable administration. This compound is being developed to combat various gram-positive bacteria, including resistant strains such as methicillin-resistant Staph...[Read more]
Industry
Biotechnology
IPO Date
2021-06-25
Stock Exchange
NASDAQ
Ticker
ACXP
According to Acurx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6766398.00. This represents a change of -99.64% compared to the average of -1887223180.26 of the last 4 quarters.
The mean historical Enterprise Value of Acurx Pharmaceuticals, Inc. over the last ten years is -1043455725.71. The current -6766398.00 Enterprise Value has changed -35.15% with respect to the historical average. Over the past ten years (40 quarters), ACXP's Enterprise Value was at its highest in in the March 2021 quarter at 72.72M. The Enterprise Value was at its lowest in in the December 2025 quarter at -7552367490.00.
Average
-1043455725.71
Median
33.94M
Minimum
-7552367490.00
Maximum
75.13M
Discovering the peaks and valleys of Acurx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 32.48%
Maximum Annual Enterprise Value = 75.13M
Minimum Annual Increase = -74459.79%
Minimum Annual Enterprise Value = -7552367490.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -7552367490.00 | -74459.79% |
| 2024 | 10.16M | -75.26% |
| 2023 | 41.06M | 20.99% |
| 2022 | 33.94M | 8.81% |
| 2021 | 31.19M | -58.48% |
| 2020 | 75.13M | 32.48% |
The current Enterprise Value of Acurx Pharmaceuticals, Inc. (ACXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2500383799.00
5-year avg
-1487205174.00
10-year avg
-1043455725.71
Acurx Pharmaceuticals, Inc.’s Enterprise Value is greater than Aprea Therapeutics, Inc. (-42010310.00), less than Adial Pharmaceuticals, Inc. (-1724361.00), less than BioCardia, Inc. (4.56M), less than HCW Biologics Inc. (8.02M), less than Galecto, Inc. (747.52M), less than Creative Medical Technology Holdings, Inc. (-123148.00), less than Kiora Pharmaceuticals, Inc. (719.67K), greater than IN8bio, Inc. (-12958522.00), less than Aptevo Therapeutics Inc. (8.24M), less than Brainstorm Cell Therapeutics Inc. (9.75M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -42010310.00 | $4.46M | |
| -1724361.00 | $2.86M | |
| 4.56M | $5.10M | |
| 8.02M | $2.67M | |
| 747.52M | $34.47M | |
| -123148.00 | $5.60M | |
| 719.67K | $11.30M | |
| -12958522.00 | $6.63M | |
| 8.24M | $10.45M | |
| 9.75M | $8.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acurx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acurx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Acurx Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Acurx Pharmaceuticals, Inc. (ACXP)?
What is the 3-year average Enterprise Value for Acurx Pharmaceuticals, Inc. (ACXP)?
What is the 5-year average Enterprise Value for Acurx Pharmaceuticals, Inc. (ACXP)?
How does the current Enterprise Value for Acurx Pharmaceuticals, Inc. (ACXP) compare to its historical average?